The medical insurance people will lose BILLIONS if fewer people get these cancers and no longer need to buy the drugs.
I fail to see how the health insurance industry would lose out due to lower claims from these cancers.
Regarding the article:
It isn't accurate in its description. Gardasil and Cervarix are not human cancer vaccines, they are viral vaccines (for viruses that can cause cancer, but are not themselves cancer).
There is only one cancer vaccine on the US market: Dendreon's Provenge. And even then, it is debatable as to whether or not it fits the classical definition for vaccine. It is not an injectable product: leukocytes are extracted from the bloodstream, then taken to a lab where they are grown in culture and functionalized to attack prostate cancer cells.
This is a very labor intensive, expensive process if compared with an injectable. Since the therapy is so recent, it also needs to recoup research and development costs, so it runs over $90k for a course of treatment. It was approved earlier this year, and I think the benefit is very marginal.
It is, however, a first in class therapeutic.
If we exclude Provenge, there are no cancer vaccines on the US market.
Real cancer vaccines are in clinical trials for FDA approval, and I suspect the earliest approved ones will be using DNA plasmid technology. DNA vaccines will be for both prophylactic and therapeutic uses.